Get Started

BBIO

NASD BridgeBio Pharma, Inc.
Oct 23, 2026 · 4:45 PM ET LAST TRADE Market Closed

$68.56 ↑ +0.00 (+0.00%) Trading Up from the previous close of $68.56, $0.30 below the day’s high of $68.86

YTD change
-10.37%
vs 20-day SMA
+3.33%
vs 200-day SMA
-5.99%

Price ranges

Previous day
$67.07 $69.32
open $67.48 close $68.12
+$0.64 (+0.95%)
Today
$67.02 $68.86
open $67.69 now $68.56
+$0.87 (+1.29%)
Past week
$65.26 $69.32
from $67.13 now $68.56
+$1.43 (+2.13%)
Past month
$62.86 $69.32
from $66.28 now $68.56
+$2.28 (+3.44%)
This year
$62.50 $93.42
from $76.49 now $68.56
-$7.93 (-10.37%)

Price & Performance

-3.55 (-4.95%) / 6M

$61.15$71.54$81.93$92.32Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 26.6% away from all-time highs of $93.42
  • BBIO is down 10% since the beginning of the year
  • BBIO is up 27% over the past 12 months
  • BBIO is up 3% over the past 1 month
  • 11% of all BBIO investors are betting against BBIO

BBIO reads very good: price sits above one of the two key moving averages, the 12-month move is +26.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.78
Earnings momentum -44.7% Quarterly EPS growth
Quarterly change -44.7%

Valuation

P/E ratio N/A
Enterprise value $16.0B
Beta 0.59

Balance sheet & scale

IncomeN/A
Revenue$713.1M
Cash$720.7M
Debt$3.4M
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $13.4B

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,306.69 +2.83%
JNJ Johnson & Johnson $267.61 +3.81%
ABBV AbbVie, Inc. $285.19 +0.14%
MRK Merck & Co., Inc. $147.24 -1.76%
RHHBY Roche Holding Ltd Sponsored ADR $59.62 +0.86%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.